Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 4/20 | 0.46 |
| ▸ | MAOB | P27338 | 3/20 | 0.46 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | CES1 | P23141 | 2/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | ANPEP | P15144 | 2/20 | 0.40 |
| ▸ | AHR | P35869 | 1/20 | 0.39 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29364777 | 0.82 | MAOA (0.65) | CYP1A2MAOAMAOBAKR1B1 | |
| SCHEMBL30487859 | 0.82 | MAOA (0.65) | CYP1A2MAOAMAOBAKR1B1 | |
| SCHEMBL44758 | 0.82 | MAOA (0.65) | CYP1A2MAOAMAOBAKR1B1 | |
| SCHEMBL149855 | 0.80 | MAOA (0.54) | CYP1A2MAOAMAOBAKR1B1CES1 | |
| SCHEMBL29011578 | 0.80 | MAOA (0.62) | CYP1A2MAOAMAOBAKR1B1 | |
| Charcoal, Activated SCHEMBL31096962 | 0.80 | MAOA (0.62) | CYP1A2MAOAMAOBAKR1B1 | |
| Hydrochloric Acid SCHEMBL29040933 | 0.80 | MAOA (0.62) | CYP1A2MAOAMAOBAKR1B1 | |
| SCHEMBL29405055 | 0.80 | MAOA (0.54) | CYP1A2MAOAMAOBAKR1B1CES1 | |
| SCHEMBL724064 | 0.77 | MAOA (0.52) | CYP1A2CYP2A6MAOAMAOBCES1 | |
| Naphthalene SCHEMBL29220450 | 0.77 | MAOA (0.58) | CYP1A2MAOAMAOBAKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024079923-A1 | RESIN COMPOSITION, CURED PRODUCT, SEMICONDUCTOR ELEMENT, AND DRY FILM RESIST | 日本化薬株式会社 | 2024-04-18 | — | — | WO | disclosed |
| CN-116940617-A | Resin composition, resin sheet, multilayer printed wiring board, and semiconductor device | 日本化药株式会社 | 2023-10-24 | — | — | CN | disclosed |
| CN-116813824-A | Resin composition, resin sheet, multilayer printed wiring board, and semiconductor device | 三菱瓦斯化学株式会社 | 2023-09-29 | — | — | CN | disclosed |
| US-20230242720-A1 | MODULUS MODIFIERS AND FILMS THEREOF | ZYMERGEN ACQUISITION SUB, INC. | 2023-08-03 | — | — | US | disclosed |
| CN-113348079-B | Resin composition, resin sheet, multilayer printed wiring board, and semiconductor device | 三菱瓦斯化学株式会社 | 2023-06-02 | — | — | CN | disclosed |
| WO-2022201621-A1 | RESIN COMPOSITION, RESIN SHEET, MULTILAYER PRINTED WIRING BOARD, AND SEMICONDUCTOR DEVICE | 日本化薬株式会社 | 2022-09-29 | — | — | WO | disclosed |
| EP-0777492-B1 | COMBINATORIAL LIBRARIES OF SUBSTRATE-BOUND CYCLIC ORGANIC COMPOUNDS | CHIRON CORP (US) | 2005-01-19 | — | — | EP | disclosed |
| EP-0777492-A4 | COMBINATORIAL LIBRARIES OF SUBSTRATE-BOUND CYCLIC ORGANIC COMPOUNDS | CHIRON CORP (US) | 2002-11-27 | — | — | EP | disclosed |
| US-5958792-A | DERIVATIZING SOLID SUPPORT SURFACES WITH A GROUP CONSISTING OF O AND NH TO PROVIDE PLURALITY OF DERIVATIZED SUPPORT SURFACES, DIVIDING THEM INTO SUBAMOUNTS, REACTING DIFFERENT SUBMONOMER WITH ACTIVE GROUP OF SUBAMOUNT, RECOMBINING | CHIRON CORPORATION (US) | 1999-09-28 | — | — | US | disclosed |
| EP-0777492-A1 | COMBINATORIAL LIBRARIES OF SUBSTRATE-BOUND CYCLIC ORGANIC COMPOUNDS | CHIRON CORPORATION (US) | 1997-06-11 | — | — | EP | disclosed |
| WO-1996040201-A1 | COMBINATORIAL LIBRARIES OF SUBSTRATE-BOUND CYCLIC ORGANIC COMPOUNDS | CHIRON CORPORATION (US) | 1996-12-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242720-A1 | MODULUS MODIFIERS AND FILMS THEREOF | SHBG, PTMS, SERPINA6 | CYP1A2 4024/4885CYP2A6 3340/4885MAOA 2706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.